QuinnS.WellsMD
Cardiology • Nashville, TNAdult Congenital Heart Disease
Assistant Professor, Medicine, Vanderbilt Univ Sch of Med
Dr. Wells is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 The Vanderbilt Clinic
Nashville, TN 37232Phone+1 615-936-2000Fax+1 615-936-0605
Education & Training
Vanderbilt University Medical CenterFellowship, Cardiovascular Disease, 2009 - 2012
Massachusetts General HospitalResidency, Internal Medicine, 2006 - 2009
University of Alabama School of MedicineClass of 2006
Certifications & Licensure
TN State Medical License 2003 - 2026
AL State Medical License 2002 - 2020
MA State Medical License 2008 - 2010
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- Genetic Testing for Cardiovascular Disease: Evidence Grows But Challenges Remain.J Lukas Laws, Giovanni E Davogustto, Quinn S Wells
Journal of the American College of Cardiology. 2025-03-18 - Genome-wide association study meta-analysis provides insights into the etiology of heart failure and its subtypes.Albert Henry, Xiaodong Mo, Chris Finan, Mark D Chaffin, Doug Speed
Nature Genetics. 2025-03-04 - 1 citationsLarge-scale multi-omics identifies drug targets for heart failure with reduced and preserved ejection fraction.Danielle Rasooly, Claudia Giambartolomei, Gina M Peloso, Hesam Dashti, Brian R Ferolito
Nature Cardiovascular Research. 2025-03-01
Press Mentions
Proteomic Signature a Key to Early Detection of Fatty Liver Disease: StudyDecember 19th, 2024
Tall People May Be More Prone to Varicose Veins: StudyNovember 2nd, 2018
Smoking Study Personalizes TreatmentNovember 16th, 2017- Join now to see all
Grant Support
- Leveraging Large-Scale Biobanks to Discover and Define Rare Variant Effects in Hypertrophic CardiomyopathyVANDERBILT UNIVERSITY MEDICAL CENTER2024–2028
- Leveraging Large-Scale Biobanks to Discover and Define Rare Variant Effects in Hypertrophic CardiomyopathyVANDERBILT UNIVERSITY MEDICAL CENTER2024–2028
- Discovery and Characterization of Rare Variant Effects in Dilated Cardiomyopathy via Large-Scale Biobank AnalysisVANDERBILT UNIVERSITY MEDICAL CENTER2023–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
